COVID-19 Oral Treatments Plan
December 27, 2021
Paxlovid and molnupiravir received emergency use authorization the week of December 20th. These oral COVID-19 medications will be critical additions to our toolbelt of treatments against COVID-19 disease. These treatments will play an important role as recent data shows that some monoclonal antibody treatments including bamlanivimab/etesevimab, REGEN-COV, and Sotrovimab are unlikely to retain activity against Omicron and the current prevalent variants . The situation is continuously changing and oral treatments will play a large role in treatment as they are expected to retain efficacy against Omicron and the current prevalent variants. Patients outside of the eligibility criteria for oral treatments should be managed using other protocols and treatments.
While supplies of oral treatments are in short supply, distribution and shipping must occur through a phased patient eligibility criteria and a limited pharmacy network will be necessary. Patients outside of the eligibility criteria for oral treatments should be managed using other protocols and treatments. Supply is anticipated to increase over the next several months.
Current Participating Pharmacy Locations for Treatments
If a patient requires their prescription be mailed to their home, please send to the Walgreens Pharmacy below:
Community, A Walgreens Pharmacy #16544
933 San Mateo Blvd NE Suite 501,
Albuquerque, NM 87108
Monday thru Friday from 8:30 am to 5:00 pm
(Weekend Prescriptions Friday 4pm thru Monday 8am need to be sent to a location with store supplies. Please see the table below.)
Prescriptions will be sent via overnight mail across the state directly to the patient’s home or an approved alternate pick up location.
Prescribers should note the date of symptom onset on the prescription. This information is critical for pharmacists to ensure the patient receives their prescription within the treatment window.